Stone House Investment Management, LLC
Position in ANAB — Anaptysbio, Inc
CIK 1696497
TUNKHANNOCK, PA
Position in ANAB
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$810
+$145 QoQ
Shares Held
12
-33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 211 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stone House Investment Management, LLC holds $549,537 across 70 Biotechnology names. ANAB ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
6,693 | $113,580 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
902 | $85,843 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
1,008 | $55,379 | |
| 4 | INSM |
INSMED Inc
|
501 | $53,416 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
1,000 | $47,040 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78 | $38,744 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
800 | $31,208 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
500 | $16,360 |
All Filings in ANAB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $810 | 12 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $665 | 12 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $630 | 13 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $153 | 5 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||